INTRODUCTION
Protein tyrosine kinases are key components of the signaling networks that regulate growth and proliferation in metazoans (Manning et al., 2002) . Although kinase activity is tightly regulated by various mechanisms, these mechanisms converge on a conserved element in the active site of the kinase domain called the activation loop. The conformation of the activation loop is responsive to phosphorylation (Huse and Kuriyan, 2002) , which stabilizes the active configuration of catalytic residues in most kinases and also promotes the binding of peptide substrates (Nolen et al., 2004) .
The catalytic domains of most tyrosine kinases are highly promiscuous (Miller, 2003) , and specificity is achieved by controlling the localization and activity of the kinase. This is exemplified by the observation that deregulation and overexpression of tyrosine kinases result in the phosphorylation of a large and heterogeneous set of proteins (Superti-Furga et al., 1993; Takashima et al., 2003; Walkenhorst et al., 1996) . C-terminal Src Kinase (Csk) is unusual among tyrosine kinases because it readily phosphorylates only one class of substrate, a conserved tyrosine in the C-terminal tails of the Src family kinases (Tyr 527 in chicken c-Src [Takeya and Hanafusa, 1983] ). This degree of specificity is retained even when Csk is highly overexpressed (Superti-Furga et al., 1993) . Phosphorylation by Csk stabilizes an inactive form of the Src kinases, in which the phosphorylated tail binds to the Src homology 2 (SH2) domain (Schindler et al., 1999; Sicheri et al., 1997; Xu et al., 1997 Xu et al., , 1999 . Csk (like its close relative Chk) is not regulated by activation loop phosphorylation and is instead active constitutively (Brown and Cooper, 1996) , a property that is consistent with the need for Csk to inhibit the Src kinases continually (Okada et al., 1991) .
Like the Src kinases, Csk possesses a Src-homology 3 (SH3) domain and an SH2 domain. The SH2 domain binds to the phosphorylated substrates of Src kinases, thereby targeting Csk to sites of Src kinase activity (Bergman et al., 1995; Howell and Cooper, 1994; Neet and Hunter, 1995; Sabe et al., 1994) . These targeting mechanisms are not critical for the specificity of Csk for the Src kinases, which is apparent in vitro. Indeed, Csk displays extremely poor activity toward tyrosine-containing peptides, with the best peptides selected from a peptide library displaying K M values in the millimolar range (Sondhi et al., 1998) . By comparison, the tyrosine kinases c-Src and c-Abl phosphorylate their optimal peptide substrates with K M values in the range of 5-50 mM (Songyang et al., 1995) . Unlike peptide substrates, constructs of c-Src that include the folded kinase domain are efficient substrates for Csk, with K M values of $5 mM (Sondhi et al., 1998) .
Here, we address two major questions regarding the specificity of Csk for the Src kinases. First, while mutagenesis experiments with Csk and c-Src have identified some of the residues involved in the interaction between the two proteins (Lee et al., , 2006 , no definitive description of the nature of the complex is as yet available. Second, while the catalytic mechanism, dynamics, and roles of the SH3 and SH2 domains of Csk have been investigated extensively (Lieser et al., , 2006 Wong et al., 2004 Wong et al., , 2005 , these studies have not clarified why the Src kinases are the only significant substrates of Csk. To address the first question, we have determined the crystal structure of a complex between the kinase domains of Csk and c-Src. This structure shows that Csk recognizes the C-terminal lobe of the c-Src kinase domain in a manner that positions the c-Src tail adjacent to the active site of Csk. To address the second question, we present a comparative analysis of the active sites of tyrosine kinases that shows that the canonical binding site for substrates is destabilized in Csk. As a consequence, Csk is efficient at phosphorylating only the Src kinases, because they present the phosphoacceptor tyrosine directly to the active site.
RESULTS AND DISCUSSION

Binding of Csk to c-Src and Crystallization of the Complex
The kinase domain of Csk is sufficient to recognize c-Src protein (Sondhi and Cole, 1999; Sun and Budde, 1999) , but the dissociation constant (K D ) for the Csk:c-Src interaction has not been measured directly. We used surface plasmon resonance to measure the binding of Csk to c-Src. Constructs of c-Src were immobilized on the sensor surface, and the binding of different constructs of Csk to the surface was monitored as a function of Csk concentration (see Figure 1A for constructs and Figure 1B for typical binding data). The affinity of Csk for c-Src is modest and highly salt dependent ( Figure 1C and Figure S1 available online). Constructs of Csk that include the SH2 domain (full-length Csk, Csk FL , and a construct lacking the SH3 domain, Csk SH2KD ) bind the kinase domain of c-Src (c-Src KD ) with K D values of $30 mM at 150 mM NaCl and $4 mM at 50 mM NaCl ( Figures 1C and  S1B ). The K D value for the kinase domain of Csk (Csk KD ) binding to c-Src KD is $70 mM at 150 mM NaCl ( Figure 1C ). When the salt dependence of the affinity is considered, these values are in agreement with reports that the Michaelis constant (K M ) for phosphorylation of c-Src by Csk is $5 mM Wang et al., 2001) .
Because of the relatively low affinity of Csk for c-Src, we were unable to purify complexes of the two proteins. We were, therefore, surprised to find that Csk KD and Csk SH2KD both crystallized readily in complex with c-Src KD when mixed together. It appears that the adventitious formation of a disulfide crosslink between Cys 290 in Csk and Cys 277 in c-Src prevented the otherwise facile crystallization of either protein separately. The disulfide bond links a Csk molecule from one enzyme-substrate complex to a c-Src molecule from a different complex ( Figure S2A ). The disulfide linkage does not appear to influence the interaction between Csk and c-Src within the biologically relevant Csk:c-Src complexes, as the interface between Csk and c-Src is essentially identical in two different crystal forms (see below), despite the fact that the disulfide-linked molecules are rotated relative to each other in the two structures ( Figure S2B ).
Crystals of either Csk KD or Csk SH2KD in complex with c-Src KD diffracted X-rays weakly. We mutated charged residues at the surface of Csk in an effort to improve crystal quality (Derewenda, 2004) , and two such mutations (Lys 361 Ala and Lys 362 Ala) improved diffraction from the Csk KD :c-Src KD crystals. While these mutations are known to decrease the activity of Csk (Lin et al., 2005) , they are distant from the Csk:c-Src interface (the Ca atom of Lys 361 of Csk is more than 20 Å from the nearest Ca atom in c-Src) and are, therefore, unlikely to influence the manner in which c-Src binds to Csk. The Csk KD :c-Src KD crystals were originally obtained in the presence of the ATP analog AMP-PNP, but the use of the nonspecific kinase inhibitor staurosporine further improved diffraction, allowing data to 2.9 Å to be measured. Staurosporine is bound to both c-Src and Csk in our structure. Structures of Csk and the Src family kinases Lck and Fyn have been determined previously in the presence of staurosporine (Kinoshita et al., 2006; Lamers et al., 1999; Zhu et al., 1999) .
We have also measured X-ray data to 4.1 Å for the Csk SH2KD : c-Src KD crystals obtained in the presence of AMP-PNP. The SH2 domain of Csk is disordered in these crystals, but the kinase domains of both Csk and c-Src are positioned reliably. Although the lower resolution of this data set provides limited information, it confirms the mode of interaction between the kinase domains of c-Src and Csk and, in one of the molecules in the asymmetric unit, allows visualization of the c-Src tail entering the Csk active site. The discussion that follows is based on the higher-resolution Csk KD :c-Src KD structure unless otherwise noted.
The Csk:c-Src Interface The interaction between c-Src and Csk is restricted to the C-terminal lobes (C lobes) of the two kinase domains and buries $1200 Å 2 of surface area between the proteins (Figure 2A ). The interaction surface on c-Src is formed by the C-terminal a helices I and I 0 (residues 508-524; see Figure 2 for the helix notation) and the loop that precedes them (residues 504-507, part of the aH/aI loop; Figure 2B ). This surface docks onto the side of the C lobe of Csk, undergoing little adjustment in structure when compared to structures of the isolated kinase domain of c-Src (Breitenlechner et al., 2005; Seeliger et al., 2007) . The interaction surface on c-Src is highly conserved among the Src family members ( Figure S3 ). The catalytically important Asp-Phe-Gly (DFG) motif of c-Src adopts an inactive conformation in this structure, but the surface of c-Src that binds to Csk is distant from the active site, and the inactive conformation of the c-Src kinase domain is unlikely to be induced by the binding of Csk.
The Csk:c-Src interface is largely electrostatic, consistent with the salt-sensitive nature of the interaction: 5 arginine residues in Figure 3A ). Helix I, comprising residues 508-519, interacts with the C lobe of Csk so as to terminate beneath the Csk active site ( Figures 3B and 3C ). The N-terminal lobe of Csk is poorly ordered ( Figure S4 ). Constructs of Csk that lack the SH2 domain have substantially reduced activity (Sondhi and Cole, 1999) , and the kinase domain of Csk is, therefore, likely to be in an inactive conformation. However, the portion of Csk that interacts with c-Src is well ordered and exhibits relatively low temperature factors (the average Ca temperature factor is 94 Å 2 for residues of Csk within 8 Å of c-Src, compared to the average temperature factor of 129 Å 2 for all Ca atoms in Csk). This region adopts a very similar conformation to that seen in the structure of full-length Csk in an active conformation (Ogawa et al., 2002) , suggesting that full-length, active Csk forms a similar complex with c-Src. This expectation is confirmed by previous mutagenesis experiments intended to investigate the determinants of the Csk:c-Src interaction (Lee et al., , 2006 . These studies predicted the importance of 6 residues (Arg 279, Arg 281, Arg 283 of Csk and Glu 510, Tyr 511, Asp 518 of c-Src) for the interaction between full-length Csk and c-Src, and all of these residues indeed make specific contacts in the Csk:c-Src interface. To further confirm the crystallographic interface, we used surface plasmon resonance to measure the effect of mutations in the Csk:c-Src interface on the interaction between Csk and c-Src. Mutation of any of the 5 arginine residues of Csk that contact c-Src interferes with binding ( Figure 3D ). Likewise, mutation of Lys 442 or Asp 518 of c-Src to alanine also prevents binding ( Figure 3D ) and interferes with the phosphorylation of c-Src by Csk ( Figure 3E ).
The c-Src Tail Is Disengaged from the Csk Active Site but Is Positioned for Ready Entry Kinase domains often bind substrates or inhibitory segments in a docking groove that lies directly beneath the active site cleft (Knighton et al., 1991) . This docking groove is utilized by Csk to bind to c-Src ( Figure 4A ). In our structure, as well as in previously determined structures of c-Src, a kink occurs in helix I between Tyr 519 and Phe 520, resulting in a separate helical turn (residues 520-524) that we refer to as helix I 0 ( Figure 4B ). The kink positions helix I 0 so that it fits snugly into the docking groove of Csk. The c-Src tail (Glu 524-Leu 533) that follows Helix I 0 does not engage the active site of Csk but extends away from Csk to bind to the C lobe of c-Src ( Figure 4B ). The side chain of Tyr 527 packs against Phe 520, extending the perpendicular aromatic:aromatic interactions that stabilize the kink between helix I and helix I 0 , and the phenol hydroxyl of Tyr 527 forms a hydrogen bond to the C-terminal carboxylate group of c-Src ( Figure 4B ). This binding mode of the c-Src tail is also seen in structures of the isolated kinase domain of c-Src (Breitenlechner et al., 2005; Seeliger et al., 2007) and in a structure of full-length active c-Src (Cowan-Jacob et al., 2005) .
That the c-Src tail can readily engage the active site of Csk is shown by aligning the crystal structure of the insulin receptor kinase (IRK), which contains a substrate peptide bound at the active site cleft (Hubbard, 1997) onto Csk in our structure. The end of helix I 0 of c-Src then approaches to within 12 Å of the tyrosine residue of the IRK peptide ($11.5 Å between the Ca atoms of Ser 522 and the tyrosine residue; Figure 4A ). The 4 residues that link the end of Helix I 0 to Tyr 527 are sufficient to span this distance. This fact is further confirmed by the lower-resolution Csk SH2KD :c-Src KD structure, which contains two Csk:c-Src complexes in the asymmetric unit. The conformations of the c-Src and Csk kinase domains in one of the complexes are similar to the structure described above, but in the other complex, the c-Src tail has disengaged from the c-Src C lobe and instead reaches into the active site of Csk. In a difference electron density map calculated using a model lacking the c-Src tail, the strongest peak (at a contour level of 5s above the mean value of the electron density) is located at the edge of the active site of Csk, just above helix I 0 ( Figures 4C and S5) . When contoured at a lower level (2.0s), the electron density is consistent with the typical manner in which peptide substrates bind to tyrosine kinases. Aligning IRK onto Csk in this structure positions the IRK substrate peptide within the electron density for the c-Src tail ( Figure 4C ).
The fact that the c-Src tail does not engage Csk in two of the three crystallographically independent complexes reported here could merely reflect the inactive nature of Csk in our crystals. Alternatively, the Csk:c-Src interface seen in the structure may be the dominant feature that determines the specific phosphorylation of c-Src by Csk, with the binding of the c-Src tail to the active site of Csk being less important. This view is consistent with several lines of evidence. The tails of the Src kinases are poorly conserved even though Csk readily phosphorylates all Src family members (Okada et al., 1991) . Most substitutions in the tail of c-Src have little impact on the kinetics of phosphorylation by Csk (Wang et al., 2001) , and a peptide comprising the sequence of the c-Src tail is an extremely poor substrate for Csk, with a value for k cat /K m that is four orders of magnitude below that for c-Src protein (Sondhi et al., 1998) .
The Anchoring of the Activation Loop of Csk Is Disrupted by a Deletion
The question remains as to why Csk does not readily phosphorylate other substrates, particularly peptide substrates. This led us to ask The canonical binding site for peptide substrates is illustrated by the substrate peptide from the structure of the insulin receptor kinase domain (IRK), shown in yellow (Hubbard, 1997) . (Right) The structure of protein kinase A, in complex with an inhibitory peptide that binds in the docking groove, is depicted for comparison (Knighton et al., 1991) . ( whether the binding site for peptide substrates, located at the base of the active site cleft, is somehow compromised in Csk. We analyzed tyrosine kinase crystal structures in which the activation loops are well ordered and in the active conformation (see Experimental Procedures). This diverse set contains six receptor tyrosine kinases and six nonreceptor tyrosine kinases. Since tyrosine kinases bind substrates in a distinct manner from serine/threonine kinases (Huse et al., 1999) , the conclusions of the analysis that follows may not apply to Ser/Thr kinases. In the active conformation, there are two distinct regions of the activation loop that are anchored onto the C lobe of the kinase domain; we refer to these as anchor points 1 and 2 ( Figure 5 ). The anchor points consist of two short antiparallel b sheets formed by interactions between two sections of the activation loop and two loops in the C lobe of the kinase (the catalytic loop and the aEF/aF loop for anchor points 1 and 2, respectively). Anchor point 1 (corresponding to residues 1155-1157 in IRK) begins 3 residues C-terminal to the catalytically important DFG motif and stabilizes the motif in the active conformation (Nolen et al., 2004;  Figure 5A ). In addition to three backbone hydrogen bonds that form the b sheet, anchor point 1 is further characterized by the insertion of the side chain of the last residue of the anchor (Ile 1157 in IRK) into a pocket on the surface of the C lobe. We refer to this residue as the hydrophobic latch, because almost all tyrosine kinases have a large hydrophobic residue at this position. Anchor point 2 forms near the C-terminal end of the activation loop (corresponding to residues 1163-1165 of IRK) and includes a tyrosine phosphorylation site when present ( Figure 5A ). The backbone amide and carbonyl groups of the tyrosine residue form two of the three hydrogen bonds to the kinase C lobe.
The two anchor points are a structurally conserved feature of the active conformation ( Figure 5B ). In all 12 structures, the distance between the Ca atom of the hydrophobic latch (the last residue in anchor point 1) and the Ca atom of the activation loop tyrosine (the first residue in anchor point 2) is between 6.2 and 7.2 Å . In contrast, the segment of the activation loop that connects anchor points 1 and 2 (referred to as the variablelength loop in this paper), as well as the portion of the activation loop C-terminal to anchor point 2, are relatively divergent in structure ( Figure 5B ).
The proximity of anchor point 2 to the C-terminal end of the activation loop, where peptide substrates bind, suggests that anchor point 2 might influence peptide binding. In particular, a conserved set of hydrophobic interactions might couple the engagement of anchor point 2 to peptide binding ( Figures 5C and  S6 ). These hydrophobic residues form a crevice on the surface of the C lobe that comprises the binding site for the side chains located one (P + 1) and three (P + 3) positions C-terminal to the substrate tyrosine (Favelyukis et al., 2001; Hubbard, 1997; Levinson et al., 2006; Mol et al., 2003) . Mutations at this binding site alter substrate specificity (Konkol et al., 2000; Songyang et al., 1995; Till et al., 1999; Yokoyama and Miller, 1999) . Two of the hydrogen bonds formed by anchor point 2 directly stabilize a residue that is part of this network of hydrophobic interactions (Phe1186 in IRK; Figures 5C and S6 ). The backbone of this residue is further linked to the peptide-binding site through the aEF/aF loop (Figures 5C and S6) . Therefore, we envisage that the engagement of anchor point 2 would stabilize these interactions and promote peptide binding. A sequence alignment of the activation loops of several tyrosine kinases demonstrates that the anchoring mechanism is disrupted in Csk ( Figure 6A ). The variable-length loop that connects anchor points 1 and 2 is completely missing in Csk and Chk. In order for the activation loop of Csk to form both anchor points simultaneously, the $6.5 Å distance between the terminal Ca atoms of the anchor points would have to be bridged by a single peptide unit, which is clearly not possible without distortion of one or both anchor points (the typical distance between Ca atoms of adjacent amino acids in proteins is 3.8 Å [Creighton, 1993] ). The engagement of anchor points 1 and 2 is, therefore, expected to be mutually exclusive in Csk. This is supported by the observation that the activation loop is at least partly disordered in all existing crystal structures of Csk. Since we expect anchor point 2 to stabilize the peptide-binding site, the engagement of anchor point 1, which is required to stabilize the DFG motif in the active conformation, could interfere with peptide binding.
Activation Loop Anchoring Affects the Activity of Csk and c-Src toward Peptides
In an attempt to restore activation loop anchoring in Csk, we made insertions in the activation loop (by introducing amino acids derived from the variable-length loop of c-Src) that would bridge the distance between anchor points 1 and 2. We also mutated the hydrophobic latch of Csk from alanine to isoleucine (the hydrophobic latch residue in c-Src). A kinetic assay demonstrates that, when Csk is engineered to contain 2 or more residues connecting the anchor points, the resulting proteins possess a 3-fold greater activity than wild-type Csk toward peptide substrates ( Figure 6B ). Insertion of a single amino acid, in contrast, has no effect on activity ( Figure 6B ). This is consistent with the architecture of the anchor points. Strikingly, all tyrosine kinases other than Csk and Chk possess a minimum of two amino acids between the anchor points.
In a previous study, replacement of the entire activation loop of Csk with that of c-Src did not result in an increase in catalytic activity . It is possible that this more extensive replacement was not accommodated by the core of the kinase domain, whereas the insertions we have made are located at the edge of the kinase domain and are, therefore, tolerated.
To further test the importance of activation loop anchoring, we deleted the variable-length loop in c-Src and mutated the hydrophobic latch residue to alanine. This c-Src mutant was well folded, as indicated by an 1 H-15 N TROSY NMR spectrum ( Figure S7 ), but displays a 10-fold reduction in activity toward peptides ( Figure 6C ). At least part of this decrease is due to an elevated K M for the peptide substrate ( Figure S7 ). These results suggest that activation loop anchoring is important for the phosphorylation of peptide substrates and that the poor activity of Csk toward peptides is at least partly a consequence of disrupted anchoring. The kinase activity of constructs of Csk containing insertions in the activation loop is shown relative to WT Csk. The constructs are referred to as CtoS-1 (for Csk to Src), CtoS-2, CtoS-3, and CtoS-4 depending on whether 1, 2, 3, or 4 residues, respectively, were inserted. The mean value and standard deviation of the relative rates from three experiments are shown. (C) The relative kinase activity of mutants of c-Src. These constructs of the kinase domain either had the hydrophobic latch mutated to alanine alone (IA) or in combination with the deletion of the variablelength loop (IA delta). The graphs show the mean and standard deviation from two experiments.
Csk Can Discriminate between Tail-Phosphorylated and Unphosphorylated c-Src
The Src kinases are localized to membranes constitutively through N-terminal myristoylation (Brown and Cooper, 1996) . The restriction of protein molecules to membrane surfaces can lead to increases in effective concentrations of as much as three orders of magnitude (Kholodenko et al., 2000) . While the affinity of Csk for c-Src in solution is relatively weak (K D $30 mM), recruitment of Csk to the membrane, which occurs when the Src kinases are activated, could potentially result in saturation of the c-Src binding sites on Csk. Therefore, we wondered whether Csk can distinguish between active and inactive Src kinases. We aligned the structure of inactive assembled c-Src (Xu et al., 1997) onto the C-terminal lobe of the kinase domain of c-Src (residues 350-520) in our structure. In this alignment, residues 523-526 of c-Src, corresponding to a portion of the phosphorylated c-Src tail, clash with Csk ( Figure 7A) . A similar result is obtained by using the structure of the inactive form of the Src kinase Hck (Sicheri et al., 1997) . Hence, we expect that Csk cannot bind these inactive forms of the Src kinases. Surface plasmon resonance experiments demonstrate that phosphorylation of c-Src on Tyr 527 by Csk prior to immobilization on the sensor surface prevents the binding of Csk to c-Src ( Figure 7B ). Clearly, Csk can discriminate between active c-Src molecules and those that have already been tail-phosphorylated, preventing inactive c-Src from competing with active c-Src for the binding site on Csk. We expect that the same mechanism is at work in Chk to distinguish unphosphorylated c-Src from phosphorylated c-Src (Chong et al., 2006) .
A surprising feature of the alignment of inactive c-Src onto the c-Src kinase domain in our structure is that the SH2/SH3 unit of c-Src is brought into close proximity to the C lobe of Csk without clashing with it. The SH3 and SH2 domains of c-Src may dock onto the c-Src kinase domain to form the assembled structure even in the absence of tail phosphorylation (Faraldo-Gomez and Roux, 2007) , so the Csk:c-Src interaction may have evolved to permit binding of assembled but unphosphorylated c-Src while discriminating against tail-phosphorylated c-Src.
The mechanism by which Csk discriminates between tailphosphorylated and unphosphorylated Src kinases would be circumvented when the Src kinases are activated by SH2 and SH3 ligands. With the SH2 domain displaced from the tail, Csk could bind to c-Src even though the tail is phosphorylated. This could potentially sequester Csk molecules and delay the downregulation of Src kinase signaling.
Conclusion
There are two distinct factors that explain the unusual specificity of Csk for the Src kinases: one that is intrinsic to Csk itself and another that depends on features that are unique to the Src kinases. The unusually short activation loop of Csk impedes the simultaneous engagement of two anchor points in the loop: one important for catalysis and one for peptide substrate binding. As a result, Csk does not readily phosphorylate most proteins. The Src kinases have evolved to circumvent the destabilized peptide-binding site by binding to Csk through a specific protein:protein interface that orients the Src kinase tail toward the active site of Csk.
Most tyrosine kinases are tightly regulated, and the disruption of their inhibitory mechanisms is frequently associated with cancer. In contrast, Csk is constitutively active under normal conditions. Csk recognizes c-Src through a proteinprotein interaction that relies primarily on electrostatic complementarity and hydrogen bonding. Such interactions have high intrinsic specificity, allowing Csk to select the Src kinases as unique targets. The inability of Csk to bind and phosphorylate substrates other than the Src kinases explains why a conventional regulatory mechanism like those of other tyrosine kinases is not critical for Csk.
EXPERIMENTAL PROCEDURES Protein Purification
The purification of the kinase domain of wild-type chicken c-Src (residues 251-533, c-Src KD ) and a construct of c-Src that contains the SH2, SH3, and kinase domains (residues 83-533, c-Src 3D ) from bacteria is described in detail elsewhere (Seeliger et al., 2005) . All constructs of Csk (Csk FL , residues 1-450; Csk SH2KD , residues 68-450; and Csk KD , residues 187-450) were expressed as fusions with glutathione S-transferase (GST). The insertions in the activation loop of Csk (Csk CtoS-1 , etc.) were made in the Csk FL background by site-directed mutagenesis, with the insertions derived from the c-Src variable-length loop (encoding Glu-Asp-Asn-Glu). Csk constructs were expressed in E. coli BL21 overnight at 18 C. Cell pellets were resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10% glycerol, 1 mM DTT) and lysed using a cell disrupter. Cleared lysate was loaded on glutathione sepharose resin (GE Healthcare). Protein was eluted with elution buffer (50 mM Bis-Tris, pH 6.0, 10% glycerol, 10 mM reduced glutathione) and cleaved with Precision Protease (Amersham) to release GST. After digestion, protein was loaded onto a HiTrap SP cation exchange column (GE Healthcare). The eluted sample was buffer-exchanged by gel filtration chromatography (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 5% glycerol).
Crystallization of the Csk:c-Src Complex Protein concentrations were determined by absorbance at 280 nm, and Csk and c-Src proteins were combined in a 1:1 molar ratio prior to crystallization. In the case of the Csk KD :c-Src KD crystals, the protein mixture was concentrated in the presence of a 2-fold molar excess of staurosporine (Sigma) prior to crystallization. The nucleotide analog AMPPNP (Sigma) was added directly to crystallization samples in the case of the Csk SH2KD :c-Src KD crystals. The crystallization samples did not include reducing agents, which in retrospect, was critical to obtaining the crystals of the complex (see Results and Discussion). Crystals of the Csk SH2KD :c-Src KD complex grew in 0.2 M sodium malonate (pH 7.0), 20% PEG 3350, while the Csk KD :c-Src KD crystals were obtained in 1.1 M sodium tartrate (pH 7.0). All crystals were cryoprotected in 25% glycerol prior to being frozen in liquid nitrogen. X-ray diffraction data were collected at the Advanced Light Source beamlines 8.2.1, 8.2.2, and 8.3.1.
Structure Determination and Refinement
Structures were solved by molecular replacement using Phaser (McCoy et al., 2005) , with models of the kinase domains of Csk and c-Src (1K9A chain A residues 188-450 for Csk, 1YOM residues 260-520 for c-Src). Refinement was performed with CNS (Brunger et al., 1998) and PHENIX (Adams et al., 2002) and model building with Coot (Emsley and Cowtan, 2004) . For the Csk SH2KD :c-Src KD structure, rigid-body refinement was performed exclusively. The SH2 domain of Csk could not be located and is not included in the model. For the Csk KD :c-Src KD structure, individual atomic refinement was performed. The model displays relatively low B factors for the c-Src kinase domain, the Csk:c-Src interface, and the portion of Csk in the vicinity of the interface ( Figure S4 ). For the rest of the Csk model, there is a strong correlation between the B factor of an individual atom and the distance of that atom from the Csk: c-Src interface. While the electron density for the c-Src kinase domain was strong, there was clear evidence of structural heterogeneity in the conformation of the activation loop of c-Src and the N-terminal lobe of Csk. We chose to model only one conformation of these segments.
Surface Plasmon Resonance Experiments
Surface plasmon resonance experiments were performed with a BIACORE 2000 instrument. c-Src protein (c-Src KD or c-Src 3D ) in 10 mM sodium acetate (pH 5.0) was coupled to the chip surface in one of the flowcells using standard amine coupling chemistry to a level of 2000 response units (RU), and a flowcell that was activated and blocked without exposure to protein was used as a reference in all experiments. A flowcell to which the kinase domains of CamKII or EGFR had been coupled was used to confirm that the binding of Csk to the surface was specific for c-Src.
Csk constructs were diluted from concentrated stocks into HPS buffer (10 mM HEPES [pH 7.5], 150 mM NaCl, 3 mM EDTA, 0.005% P20 surfactant and 2 mM TCEP, a reducing agent that precludes disulfide bond formation between Csk and c-Src). Because of rapid binding kinetics, 60 s injections were sufficient to reach equilibrium. The equilibrium response values obtained from injections of Csk at different concentrations were fit to a ''one site-specific binding'' model using GraphPad Prism version 5.0a (www.graphpad.com) to derive the dissociation constant of the interaction.
Kinetic Assays
The phosphorylation of peptides by constructs of Csk and c-Src was measured using a coupled kinase assay (Seeliger et al., 2005) in reaction buffer (100 mM Tris-HCl [pH 8.0], 10 mM MgCl 2 , 1 mM TCEP) with 1 mM ATP and either 500 nM Csk or 16 nM c-Src. The peptide sequences used were the optimal peptide substrate for c-Src (AEEEIYGEFEAKKKK) at 1 mM and the optimal peptide substrate for Csk (KKKKEEIYFFF) at 250 mM. Peptides were prepared by Dr. David King (University of California, Berkeley).
The phosphorylation of c-Src mutants by Csk was assayed by measuring the incorporation of 32 P phosphate into c-Src. To avoid complications due to c-Src autophosphorylation, an inactive mutant form of c-Src was used (Lys 295 Met). Reactions were performed in 60 mM Tris-HCl (pH 8.0), 30 mM NaCl, 50 mM unlabeled ATP, 0.5 mCi of g 32 P ATP, 2 mM MnCl 2 , 10 mM DTT, 200 mg/ml BSA with 5 nM Csk, and 5 mM c-Src for 2 min at 30 C. Radioactivity was quantified using phosphorimaging with a typhoon imager (GE Healthcare). Under these conditions, the phosphorylation of c-Src is linear with time (Wang et al., 2001 ).
NMR Spectroscopy
15 N-labeled c-Src KD constructs were expressed in standard M9 media with 15 N ammonium chloride as the sole nitrogen source and purified as described above. Proteins were concentrated to 250 mM and exchanged into 100 mM MES (pH 5.8), 200 mM NaCl, 1 mM DTT, 250 mM Dasatinib, and 10% D2O. 1 H-15 N Trosy NMR spectra (Pervushin et al., 1997) were recorded at 303 K on a Bruker Avance 800 MHz (18.8T) spectrometer, processed with NMRPipe, and visualized in NMRdraw (Delaglio et al., 1995) .
Structural Alignments of Active Kinases
The 12 tyrosine kinases (PDB codes in parentheses) used in the comparative analysis are Lck (3LCK; Yamaguchi and Hendrickson, 1996) , Fyn (2DQ7; Kinoshita et al., 2006) , c-Abl (2F4J; Young et al., 2006) , IRK (1IR3; Hubbard, 1997) , insulin-like growth factor 1 receptor (1K3A; Favelyukis et al., 2001 ), epidermal growth factor receptor (2GS6; Zhang et al., 2006) , c-Kit (1PKG; Mol et al., 2003) , fibroblast growth factor receptor (2PVF; Chen et al., 2007) , Ret (2IVV; Knowles et al., 2006) , Syk (1XBA; Atwell et al., 2004) , Janus kinase 3 (1YVJ; Boggon et al., 2005) , and Fes (3BKB).
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